A clinical trial is underway to test if a drug for a rare bone marrow cancer works as an experimental coronavirus treatment. Researchers compared patients taking 20mg of selinexor orally three times a week for two weeks to patients taking a placebo'We're encouraged by what we are seeing,' Karyopharm CEO Dr Michael Kauffman told NBC Boston. Selinexor isn't the only cancer drug being used as an experimental treatment for COVID-19, the disease caused by the virus. Chimerix, a company based in North Carolina is planning a clinical trial to test if drug derived from the blood thinner heparin for a form of leukemia reduces bleeding and inflammation in coronavirus patients. In the US, there are currently more than 1.4 million confirmed cases of the virus and more than 85,000 deaths.

Source: Daily Mail May 14, 2020 19:33 UTC